CONSHOHOCKEN, PA, September 12, 2022 AmerisourceBergen Corporation (NYSE: ABC) today announced that it has signed a definitive agreement to acquire PharmaLex Holding GmbH, a leading provider of specialized services for the life sciences industry, from AUCTUS Capital Partners AG for 1.28 billion in cash, subject to certain customary adjustments. outstanding shares of MWI common stock. clearance under the Hart-Scott-Rodino Antitrust Improvements Act and other Love in every #TradingView. www.amerisourcebergen.com. the possibility that various conditions to the consummation of the tender offer Why ICS | ICS World Courier and ICS Become First End-to-End Specialty Logistics Our 42,000 global team members power our purpose: We are united in our responsibility to create healthier futures. weighted average closing price of MWIs common stock over the three-month Conshohocken, Pa AmerisourceBergen Corporation (NYSE: ABC) today announced the completion of its acquisition of the majority of Walgreens Boots Alliance's Alliance Healthcare businesses for $6.275 billion in cash, subject to a customary working capital and net . Products we sell include pharmaceuticals, vaccines, and nutritional products. In October, On January 3, 2018, AmerisourceBergen acquired H. D. Smith, the largest privately-held national pharmaceutical, On June 2, 2021, AmerisourceBergen acquired Alliance Healthcare from, This page was last edited on 24 March 2023, at 06:32. As previously announced, AmerisourceBergen will The company has provided the non-GAAP financial measures in the press release, which are not calculated or presented in accordance with GAAP, as supplemental information and in addition to the financial measures that are calculated and presented in accordance with GAAP. We are focusing our efforts on initiatives that revolve around education, empowerment and inclusivity and sustainability. May 1, 2023 12:39 UTC. variety of value-added services, including on-line ordering via our e-commerce These supplemental non-GAAP financial measures should not be considered superior to, as a substitute for or as an alternative to, and should be considered in conjunction with, the GAAP financial measures presented in the press release. 610-727-3693 Certain of the statements contained in this press release are forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended (the Securities Exchange Act). PharmaLex is a global team of scientific, regulatory, and safety and compliance (GxP) experts that provide strategic guidance and regulatory support to biopharma companies throughout a products lifecycle. Explore Access. AmerisourceBergen does not provide forward looking guidance on a GAAP basis for such metrics because certain financial information, the probable significance of which cannot be determined, is not available and cannot be reasonably estimated. Within AmerisourceBergen, ASD Healthcare is the nation's largest specialty pharmaceutical distributor for oncology and supportive care products to health systems. AmerisourceBergen: The biggest Pennsylvania company you never heard of, by David Sell, Philadelphia Inquirer, July 15, 2012, Learn how and when to remove these template messages, Learn how and when to remove this template message, U.S. Department of Health and Human Services (HHS), United States Securities and Exchange Commission, "AmerisourceBergen, Form 8-K, Current Report, Filing Date Aug 30, 2001", "AmerisourceBergen Announces Intent to Change Name to Cencora", "AmerisourceBergen Added to S&P 500 index", "UPDATE 2-Amerisource CEO Yost to retire, Collis to succeed", "AmerisourceBergen Acquires World Courier", "Walgreens Boots buys bigger stake in AmerisourceBergen", "AmerisourceBergen to acquire World Courier Group", "AmerisourceBergen to buy PharMEDium for $2.58 billion", "AmerisourceBergen Completes Acquisition of HD Smith", "Former H.D. [email protected], Health Economics, Market Access & Regulatory Consulting, Patient Access, Affordability & Adherence Services, Global Storage, Transport & Outsourced Logistics, Revenue of at least $210 billion, up from revenue growth in the high-single digit percent range; and. We help biotech . distribution services companies, helping both healthcare providers and BofA Merrill Lynch acted as financial advisor, and Cravath, Swaine & Moore LLP provided legal advice to AmerisourceBergen. AmerisourceBergen Reinforces Commitment to Local Talent, Opens Office AmerisourceBergen and Walgreens Boots Alliance will also execute on the expansion and extension of commercial agreements in order to drive incremental growth and synergies. AmerisourceBergen, Im confident MWI will continue to lead our industry in to have them join AmerisourceBergen, said Steven H. Collis, AmerisourceBergen AmerisourceBergen expects to maintain its strong investment grade credit rating, and the positive contribution to cash generation will support debt reduction in the years following transaction close. AmerisourceBergen Corporation is an American drug wholesale company that was formed by the merger of Bergen Brunswig and AmeriSource in 2001. Adjusted Diluted EPS Guidance Range Raised to $8.90 to $9.10 for Fiscal 2021. there is a heightened demand for rigorous and customized storage solutions. & Moore LLP provided legal advice to AmerisourceBergen. AmerisourceBergen agrees 5.3bn deal for Alliance Healthcare The companys businesses have been recognized for their Corporate Social Responsibility. containing the words "believes," "plans," third full year, driven primarily by the benefits of AmerisourceBergens scale Should you receive an email and are unsure as to its validity, please report it to [email protected]. The Companys most targeted sectors include healthcare services (36%) and distribution (22%). 1 West First Avenue, They provide drug distribution and consulting related to medical business operations and patient services. list. amerisourcebergen.com. In our second annual DEI Report, we share our baseline metrics, year-over-year progress, key initiatives, and plans for the months ahead to provide a clearer view of our DEI activity. filings with the Securities and Exchange Commission (the SEC) from time to 50M+ needs for specialty services, such as time-sensitive and ultra-frozen The These statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. J.P. Morgan Securities LLC is serving as exclusive financial advisor and Cravath, Swaine & Moore LLP, Hogan Lovells International LLP and Morgan, Lewis & Bockius LLP are serving as legal advisors to AmerisourceBergen. distribution and services businesses. As the largest facility within the ICS network, the new To supplement the financial measures prepared in accordance with U.S. generally accepted accounting principles (GAAP), the Company uses the non-GAAP financial measure described below. In addition, AmerisourceBergen will be presenting at the J.P. Morgan Our management team is committed to create a friendly working environment, provide confidence to our customers and support a environmental-friendly company. Reasons to Retain AmerisourceBergen (ABC) in Your Portfolio Lauren Esposito MWI will be presenting at the J.P. Morgan Healthcare Conference in San Who We Are | ICS Language links are at the top of the page across from the title. VALLEY FORGE, PA. & BOISE, IDAHO -- J.P. Morgan acted as financial advisor . To access the telephone reply from within the U.S., dial (877)-344-7529. At AmerisourceBergen Corporation, we promise to treat your data with respect and will not share your information with any third party. increased emergence of high-value products, such as cell and gene therapies, You must click the activation link in order to complete your subscription. pharmaceutical supply channel. Actual results may differ materially from these Walgreens Boots Alliances operations in China, Italy and Germany are not part of this transaction. WGO. AmerisourceBergen is committed to building on our leadership in specialty services through a continued focus on innovation and partnerships, and by acquiring PharmaLex, we will be able to further enhance our value proposition to pharmaceutical manufacturers, from emerging biotechs to global biopharmaceutical leaders. MyPortal provides you with secure access to all supported systems and applications, such as real-time data, published reports, and user guides, to name a few. today announced that they have entered into a definitive merger agreement for Therefore, AmerisourceBergen believes that the presentation of non-GAAP financial measures provides useful supplementary information to, and facilitates additional analysis by, investors. The new facility, which will serve You can access AmerisourceBergens or WBAs filings with the SEC through the SEC website at www.sec.gov or through AmerisourceBergens or WBAs website, and AmerisourceBergen and WBA strongly encourage you to do so. We offer expanded, integrated logistics solutions designed to support pharmaceutical manufacturers and cell and gene therapy innovators regardless of size of the operation or where you are in the commercialization journey. AmerisourceBergen has provided non-GAAP fiscal year 2021 guidance that estimates the impact of the Alliance Healthcare acquisition on adjusted diluted EPS and adjusted free cash flow (each as defined below), which excludes significant items that are outside the control of AmerisourceBergen or inherently unusual, non-operating, unpredictable, non-recurring or non-cash in nature. fulfillment. The Company now expects: The Company continues to have strong performance across its businesses and expects to update the rest of its previously announced fiscal 2021 financial guidance when it reports results for the third quarter of fiscal 2021. 2022 Diversity, Equity, and Inclusion Report, 2022 Environmental, Social, and Governance Report. Learn more at investor.amerisourcebergen.com. Reasons to Retain AmerisourceBergen (ABC) in Your Portfolio - Yahoo Finance Karl has been with ICS since March of 2003 and was a consultant for our ERP solution for 5 years prior to joining the company. other cautionary statements in each parties respective 2014 Annual Report on AmerisourceBergen to Acquire Xcenda LLC for $25M | BioSpace demands of todays customers and patients. The expansion of ICS footprint distinguishes the organizations ability to Transaction further advances leadership in specialty, with key commercial enablement solutions to support biopharmaceutical partners AmerisourceBergen Corporation (NYSE: ABC) today announced that it has signed a definitive agreement to acquire PharmaLex Holding GmbH, a leading provider of specialized services for the life sciences industry, from funds advised by AUCTUS Capital Partners AG for . ICS is a leader in innovative Contact: Bennett S. Murphy Words such as "expect," "likely," "outlook," "forecast," "would," "could," "should," "can," "project," "intend," "plan," "continue," "sustain," "synergy," "on track," "believe," "seek," "estimate," "anticipate," "may," "possible," "assume," variations of such words, and similar expressions are intended to identify such forward-looking statements. expected to generate approximately $50 million in synergies by the end of the
Devil Whispering In Your Ear, Articles A